Atossa Therapeutics (ATOS) enters reverse-split Monday as Nasdaq compliance clock tightens
Atossa Therapeutics will enact a 1-for-15 reverse stock split Monday, after shares closed Friday at $0.565, down 6%. The move aims to lift the price above Nasdaq’s $1 minimum ahead of a Feb. 17 compliance deadline. Shares will trade under a new CUSIP and fractional shares will be paid out in cash. Options contracts will be adjusted to reflect the split.
